Featured Interview: CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY)

Featured Interview: CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY)

  CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY), returns to Stock Day to give a detailed update on status of clinical trials for Pro 140, fast tracking with the FDA for final approval, and hopes to bring to market by 2020.

 

The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.

Close Menu